Showing 1 - 20 results of 51 for search '"atherogenesis"', query time: 0.05s Refine Results
  1. 1

    Protocol to generate a 3D atherogenesis-on-chip model for studying endothelial-macrophage crosstalk in atherogenesis by Katie M.L. Hanford, Kim E. Dzobo, Miranda Versloot, Jorge Peter, Jeffrey Kroon

    Published 2025-03-01
    “…Summary: The endothelium is the gatekeeper of vessel health, and its dysfunction is pivotal in driving atherogenesis. Here, we present a protocol to replicate endothelial-macrophage crosstalk during atherogenesis, called the “atherogenesis-on-chip” model, based on the Emulate dual-channel perfusion system. …”
    Get full text
    Article
  2. 2

    C-Reactive Protein in Human Atherogenesis: Facts and Fiction by Oliver Zimmermann, Kefei Li, Myron Zaczkiewicz, Matthias Graf, Zhongmin Liu, Jan Torzewski

    Published 2014-01-01
    “…Whereas initial experimental studies suggested a pathogenic role for CRP in atherogenesis, more recent genetic data from Mendelian randomization trials failed to provide evidence for a causative role of CRP in cardiovascular disease. …”
    Get full text
    Article
  3. 3

    Overweight: atherogenesis risk marker in children between 8 and 9 years by Beatriz Sabina Roméu, Margarita Rosa Romeu Escobar, Juan José Apolinaire Pennini

    Published 2008-12-01
    “…<strong><br />Objectives:</strong> To determine differences in the emergence of atherogenesis risk factors in children between 8 and 9 years with normal weight and overweight. …”
    Get full text
    Article
  4. 4

    An Effect of Ursodeoxycholic Acid on Inflammation, Steatosis and Liver Fibrosis and Atherogenesis Factors in Patients with Non-Alcoholic Fatty Liver Disease: Results of the USPEH Study by M. V. Mayevskaya, M. Yu. Nadinskaia, V. D. Lunkov, I. Yu. Pirogova, E. V. Chesnokov, Kh. B. Kodzoeva, V. T. Ivashkin

    Published 2020-01-01
    “…To evaluate effects of ursodeoxycholic acid (UDCA) on inflammation, steatosis and liver fibrosis and atherogenesis factors in patients with non-alcoholic fatty liver disease (NAFLD).Materials and methods. …”
    Get full text
    Article
  5. 5
  6. 6
  7. 7
  8. 8

    Nitric oxide function in atherosclerosis by K. E. Matthys, H. Bult

    Published 1997-01-01
    “…It is now appreciated that endothelial dysfunction is an early event in atherogenesis and that it may also involve the microcirculation, in which atherosclerotic lesions do not develop. …”
    Get full text
    Article
  9. 9

    FXR activation reduces the formation of macrophage foam cells and atherosclerotic plaque, possibly by down regulating hepatic lipase in macrophages by Qiang Gu, Jia Liu, Li Li Shen

    Published 2025-02-01
    “…Nevertheless, the mechanisms that promote formation of foamy macrophages during atherogenesis remain poorly understood. This study explored the effects of Farnesoid X receptor (FXR) and hepatic lipase (HL, encoded by LIPC) on atherogenesis, particularly in foamy macrophage formation. …”
    Get full text
    Article
  10. 10

    Diverse Roles of Macrophages in Atherosclerosis: From Inflammatory Biology to Biomarker Discovery by Ting Gui, Aiko Shimokado, Yujing Sun, Takashi Akasaka, Yasuteru Muragaki

    Published 2012-01-01
    “…Based on the central functions of macrophages in atherogenesis, cytokines, chemokines, enzymes, or microRNAs related to or produced by macrophages have become important clinical prognostic or diagnostic biomarkers. …”
    Get full text
    Article
  11. 11

    Distinct Functions of Specialized Dendritic Cell Subsets in Atherosclerosis and the Road Ahead by Alma Zernecke

    Published 2014-01-01
    “…Furthermore, an outlook on future challenges faced when studying DCs in this detrimental disease are provided, and hurdles that will need to be overcome in order to enable a better understanding of the contribution of DCs to atherogenesis are discussed, a prerequisite for their therapeutic targeting in atherosclerosis.…”
    Get full text
    Article
  12. 12

    Diabetes and Coronary Heart Disease: A Risk Factor for the Global Epidemic by Maguy Chiha, Mario Njeim, Edgar G. Chedrawy

    Published 2012-01-01
    “…In this we will paper focus on type 2 diabetes mellitus as a risk factor for coronary heart disease, review the mechanisms of atherogenesis in diabetics, the impact of hypertension and the treatment goals in diabetics, the guidelines for screening, and review the epidemiologic consequences of diabetes and heart disease on a global scale. …”
    Get full text
    Article
  13. 13

    Hyperglycemia and Endothelial Dysfunction in Atherosclerosis: Lessons from Type 1 Diabetes by Steven Daniel Funk, Arif Yurdagul, A. Wayne Orr

    Published 2012-01-01
    “…However, the hyperglycemia that defines the diabetic condition independently affects atherogenesis in cell culture systems, animal models, and human patients. …”
    Get full text
    Article
  14. 14

    Atherogenic Factors and Their Epigenetic Relationships by Ana Z. Fernandez, Andrew L. Siebel, Assam El-Osta

    Published 2010-01-01
    “…Hypercholesterolemia, homocysteine, oxidative stress, and hyperglycemia have been recognized as the major risk factors for atherogenesis. Their impact on the physiology and biochemistry of vascular cells has been widely demonstrated for the last century. …”
    Get full text
    Article
  15. 15

    Role of Matrix Metalloproteinase-8 in Atherosclerosis by Sébastien Lenglet, François Mach, Fabrizio Montecucco

    Published 2013-01-01
    “…In this paper, we will update and comment on evidence of the most relevant regulatory pathways and activities mediated by MMP-8 in atherogenesis.…”
    Get full text
    Article
  16. 16

    Insulin Resistance: A Proinflammatory State Mediated by Lipid-Induced Signaling Dysfunction and Involved in Atherosclerotic Plaque Instability by Fabrizio Montecucco, Sabine Steffens, François Mach

    Published 2008-01-01
    “…Insulin resistance increases atherogenesis and atherosclerotic plaque instability by inducing proinflammatory activities on vascular and immune cells. …”
    Get full text
    Article
  17. 17

    Oxidative Stress in Cardiovascular Inflammation: Its Involvement in Autoimmune Responses by Elisabetta Profumo, Brigitta Buttari, Rachele Riganò

    Published 2011-01-01
    “…Accelerated atherosclerosis has been reported in patients with autoimmune diseases, suggesting an involvement of autoimmune mechanisms in atherogenesis. Different self-antigens or modified self-molecules have been identified as target of humoral and cellular immune responses in patients with atherosclerotic disease. …”
    Get full text
    Article
  18. 18

    Drugs Involved in Dyslipidemia and Obesity Treatment: Focus on Adipose Tissue by Sofia Dias, Sílvia Paredes, Laura Ribeiro

    Published 2018-01-01
    “…Specifically, we explored how these drugs can modulate the complex pathways involved in metabolism, inflammation, atherogenesis, insulin sensitivity, and adipogenesis. …”
    Get full text
    Article
  19. 19

    The Immune Response Is Involved in Atherosclerotic Plaque Calcification: Could the RANKL/RANK/OPG System Be a Marker of Plaque Instability? by Fabrizio Montecucco, Sabine Steffens, François Mach

    Published 2007-01-01
    “…Atherogenesis is characterized by an intense inflammatory process, involving immune and vascular cells. …”
    Get full text
    Article
  20. 20

    Vascular cytoprotection, autoimmune disease, and premature atherosclerosis by Justin C Mason

    Published 2018-01-01
    “…Systemic inflammatory diseases including rheumatoid arthritis and systemic lupus erythematosus are associated with endothelial dysfunction, increased aortic stiffness, and accelerated atherogenesis. Premature cardiovascular disease is well-recognized feature of many rheumatic diseases. …”
    Get full text
    Article